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Abstract:  
Background: Despite the increasing incidence of  Prostate cancer, there has not been any focused screening policy or strategy 
in sub-Saharan Africa including Nigeria. 
Objectives: To assess the level of  awareness and uptake of  PSA screening test and their determinants in a Nigerian community. 
Methods: A cross-sectional population survey of  men with no prior history of  prostate cancer was carried out. Logistic re-
gression analysis was used to determine the effect of  identified variables in predicting awareness and uptake of  prostate cancer 
screening. 
Results: Mean age was 51.5±9.8 years; a few men (31, 16.9%) had ever heard of  the screening test and most got the information 
from health centers. A low proportion (8, 4.4%) had taken the screening test. Men with incomes above poverty line (OR = 11.7 
2.8–50.1, p = .001) or those with health insurance (OR = 2.7 1.2–6.5, p = .023) were significantly more likely to be aware of  the 
test. Only the men with higher incomes (OR = 25.6 5.8–114.2, p = .0001) were significantly more likely to have taken the test. 
Conclusion: Higher incomes and health insurance status impact screening awareness but only income status determines if  men 
subsequently proceed to take the PSA screening test.
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Introduction
Over the last four decades, the incidence of  Prostate can-
cer (PCa) has been observed to be increasing in sub-Saha-
ran African Black men.1-3  Despite this, there has not been 
any focused PCa screening or control policy / strategy in 
many of  the sub-Saharan countries including Nigeria.3,4 
However, prostate specific antigen (PSA) screening tests 
are increasingly available in many urology clinics though 
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many primary and secondary care centers still lack access 
to the test. The decision to proceed to screening tests 
for a Nigerian man typically follows a subject-physician 
discussion on the subject’s PCa risk and then shared deci-
sion process between the subject and the physician/urol-
ogist. Whenever this interaction occurs, Nigerian men 
seem to display strong willingness to undergo screening 
especially when no or very minimal costs are involved.4 
Never-the-less, widely-reported observations of  a lack of  
awareness of  and poor uptake of  PSA screening among 
Nigerian men (and other sub-Saharan African men) com-
pared with most of  the rest of  the world continues to be 
made.5 In general, baseline cancer awareness and aware-
ness of  cancer screening tests is less than 40% and 20% 
respectively in at-risk populations of  sub-Saharan Afri-
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ca.5  A probable consequence of  this challenge to can-
cer care and control is the very high incidence of  late 
presentations with advanced disease and a high mortality 
from the disease.5-7 Generally, it is thought that the low 
uptake of  cancer screening opportunities may be related 
to barriers to accessing health care and weak health sys-
tems in most parts of  sub-Saharan Africa.5,8 PCa remains 
the most commonly diagnosed male cancer in Nigerian 
men and the vast majority of  presentations are at late in-
curable stage.9,10 There is thus an urgent need to evalu-
ate the specific determinants of  low awareness and poor 
uptake of  PCa screening (PSA test). This would provide 
evidence-based guides to policy makers and allow target-
ed interventions to improve the awareness and uptake of  
PCa screening test. This study was conducted in Nigerian 
men, the largest population of  native African black men, 
to assess the determinants of  awareness and uptake of  
PCa screening tests.
Material and methods
This was a cross-sectional population survey conducted 
in Ilorin, North-Central Nigeria over a 3-month period 
(July - September) in 2016. The target population were 40 
to 70-year-old men with no prior history of  PCa. Based 
on an assumption that the anticipated population propor-
tion of  PSA screened males is unlikely to exceed 10%;3,11-
13 the estimated minimum sample size required for a 5% 
degree of  precision and at 95% confidence interval was 
determined to be 138. We included a 30% increase over 
our calculated sample size to account for incomplete/
ineligible responses. These men were recruited by con-
venient sampling from work places, markets and bus sta-
tions by trained interviewers. Only consenting men who 
fulfilled the inclusion criteria and volunteered to complete 
the questionnaire were included in the study. Study par-
ticipants were requested to fill a structured questionnaire 
which included demographic questions, health insurance 
status, awareness of  prostate cancer and its screening, 
family history of  prostate cancer, and history of  previous 
prostate cancer screening. Information on income lev-
els that were collected were grouped based on the 2015 
World Bank defined absolute poverty line of  $1.90/day. 
Potential personal identifiers were removed from data 
obtained from subjects to maintain confidentiality. 
Data was entered and analyzed using the Statistical Pack-
age for the Social Sciences (SPSS, Inc., Chicago, IL, USA) 
version 21. Characteristics of  the study population were 
summarized by means ± standard deviation and counts 
(%). Logistic regression analysis was used to explore the 
effect of  subjects’ characteristics in predicting awareness 
and uptake of  prostate cancer screening. The level of  sig-
nificances used was p < 0.05. The study was approved 
by the Ethical and Review Committee of  University of  
Ilorin Teaching Hospital, Nigeria and written informed 
consent was obtained from all the recruited subjects.
Results
One hundred and eighty-three men consented to the 
study and adequately completed the questionnaires for 
analysis, response rate being 96%. Mean age was 51.5±9.8 
years and one-quarter of  the respondents had incomes 
below what World Bank defined absolute poverty; about 
three-quarters had secondary education or more and a 
similar proportion had no health insurance (Table 1). Only 
half  of  respondents in this study (92, 50.3%) had ever 
heard of  PCa and a smaller proportion (31, 16.9%) had 
ever heard of  the PSA screening test. For men who had 
heard of  PSA screening, the main source of  the health 
information was from health centers (17, 54.8%); others 
got the information from newspapers (3,9.7%), online (5, 
16.1%) and other mass media sources (6, 19.4%).  
We found that only a few men (13, 7.1%) had ever had 
the PSA test done and five of  these men had the PSA test 
done in the last 12 months. Of  respondents who had a 
PSA test done, only eight (4.4%) had the tests for screen-
ing purposes with the remainder done to evaluate urinary 
symptoms. Majority of  the men (167, 91.3%) had never 
had rectal or prostate examination. Although one-fifth of  
the men (40, 21.9%) knew of  men with PCa, only a few 
(5, 2.7%) had a history of  PCa in a close male relative 
(father, brother or uncle).
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 Table 1: Demographic characteristics of respondents 
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On univariate logistic regression, men with incomes 
above the 2015 World Bank poverty line (OR = 11.8 
2.8–50.4, p = 0.001), tertiary educated men (OR = 3.5 
1.4–9.0, p = 0.009), or those who had health insurance 
coverage (OR = 3.7 1.7–8.3, p = 0.001) were significantly 
more likely to be aware of  the PSA test than those be-
low the poverty line, less educated or without health in-
surance respectively (Table 2). However, on multivariate 
analysis only the poverty status (OR = 11.7 2.8–50.1, p = 
0.001) and health insurance status (OR = 2.7 1.2–6.5, p 
= 0.023) remained statistically significant (Table 2). With 
regards to the likelihood of  having had a PSA test done, 
men with incomes above the poverty line (OR = 25.8 
5.8–114.9, p = 0.0001) and those with health insurance 
(OR = 3.5 1.1–10.8, p = 0.034) were significant more 
likely than those with incomes below the poverty line or 
those without insurance respectively; there was also no 
significant difference between tertiary educated men and 
those with less education with regards to likelihood to 
have had a PSA test on univariate analysis (Table 2). On 
multivariate analysis, only the poverty status (OR = 25.6 
5.8–114.2, p = 0.0001) remained a statistically significant 
predictor of  uptake of  PSA testing.
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Table 2: Univariate and multivariate regression analysis of potential  
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Discussion
Evidence abound that PCa is the most commonly diag-
nosed cancer in Nigerian men;5,14 despite this, there are no 
focused health policies or strategies for PCa screening or 
control programs in Nigeria. Unlike most other countries 
with significant PCa burdens, population screening nev-
er took hold in Nigeria. Recent recommendations now 
advocate for individualized screening which is somewhat 
the way PSA screening test is now administered in Nige-
ria though without any coordination and/or strategy. 
It has been observed that PCa screening awareness and 
uptake of  the PSA test are abysmally low in the country 
and this study further confirms these observations.13,15,16 
We found that only 16.9% of  respondents were aware of  
the PSA screening test which is fairly similar to the 13.7% 
found in a study of  out-patient clinic attendees carried 
out in South-West Nigeria.13 Oranusi and colleagues how-
ever found a much higher level of  awareness of  56.8% 
in their study of  20 to 69 year-old male public servants 
in South-East Nigeria;11 this may be due to a wider age 
range study sample and selection of  only employed pub-
lic servants. 
Though we found that 7.1% of  respondents in our study 
had at least one PSA test conducted only a dismal 4.4% 
had the test done in the context of  PSA screening. The 
level of  test uptake found in our study is lower than the 
6.4% found in South-East Nigerian survey of  public ser-
vants, the 8.2% found in a South-West Nigerian single 
center hospital-based study and much lower than the 
17.1% found in a survey of  men participating in a health 
screening program in a large Nigerian city.11,13,16 The high-
er values seen in these studies may be the result of  a se-
lection bias inherent in the evaluation of  only male public 
servants, similar bias often seen in hospital-based study 
of  ill patients and the bias related to the potentially better 
health seeking behaviour of  attendees of  a health screen-
ing program respectively. Similar studies in the West Afri-
can sub-region revealed similar values to this index study 
with the PSA screening uptake in Ghana and Senegal 
being 2.5% and 3% respectively.3,12 We believe that our 
population survey of  ‘at risk’ men potentially provides a 
more accurate value of  the uptake of  PCa screening/PSA 
testing in Nigerian men though we acknowledge that with 
the self-report nature of  the data and the consequent pos-
sible provision of  socially acceptable responses by some 
respondents, the true value may even be lower.
Perhaps of  greater importance are the determinants of  
the observed poor awareness and poor uptake of  PSA 
screening test; this study, to the best of  our knowledge, is 
the first to evaluate this important knowledge gap in the 
West African sub-region. We found that poverty and a 
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lack of  health insurance negatively impacted being aware 
of  the PSA screening test significantly. Our findings are 
similar to that of  a North American survey which found 
that annual visits to a doctor, higher educational levels, 
and greater take-home pay were significantly related to 
the awareness of  the PSA screening test.17 These findings 
may be because men with health insurance coverage are 
generally able to pay more frequent visits to points of  
health care without incurring catastrophic health-related 
expenditures and they potentially have increased access 
to health information which can impact their awareness 
of  PSA screening tests. It is also thought that unafford-
able out-of-pocket costs required to pay a visit to a health 
care center for poor individuals without health insurance 
prevents them from accessing health information includ-
ing those about screening. The mass media has not been 
effectively deployed in disseminating health information 
on PSA screening in Nigeria and this study found that 
most men got information about PSA screening through 
contact with health personnel in health care centers. De-
ploying the mass media can be very effective as recently 
demonstrated during the control of  the Ebola pandemic 
in Nigeria.18
We found that poverty and a lack of  health insurance sig-
nificantly impacted the uptake of  PSA screening test neg-
atively. Surprisingly, we found no significant relationship 
between being well educated and accepting to have the 
PSA test. This may be related to the high unemployment 
rate in the region and that having tertiary education does 
not necessarily mean an ability to earn high incomes as 
many are under-employed, under-paid or outright unem-
ployed. Thus the ability to afford the test plays the more 
important role in test uptake. Our findings are similar 
to results from a study of  African American men which 
revealed that income levels and health insurance status 
but not educational level were determinants of  uptake of  
PSA screening tests.19  A study which queried the 2013 
Namibia Demographic and Health Survey found that 
older men, higher income, secondary education or higher 
and men with health insurance were more likely to un-
dergo screening for PCa.8 They also found that effect of  
health insurance status remained robust even after con-
trolling for demographic and socio-economic variables.8 
This finding is most probably related to the well-known 
disparities in health care utilization  among individuals 
with or without health insurance. However, we found on 
multivariate analysis that only the poverty status and not 
health insurance status remained statistically significant. 
We believe this may be the consequence of  poor health 
insurance coverage levels and critically - the non-inclusion 
of  cancer screening programs and tests in the country’s 
health insurance scheme.5 Out-of-pocket expenditures 
thus remains the major means of  getting screened and 
only men with higher incomes can afford it. 
This study has some limitations which include its 
cross-sectional design. This makes it difficult to establish 
a causal relationship between poverty or health insurance 
status and PSA screening awareness or test uptake. We 
are unable to conclude, for instance, if  men with health 
insurance or higher incomes are more likely to be aware 
of  PSA screening or whether the men who are aware of  
PSA screening are more likely to seek out health insur-
ance or funds. Another limitation is the self-report na-
ture of  the data and the possible introduction of  the bias 
of  provision of  socially acceptable responses by some 
respondents; the study could not physically validate the 
responses of  respondents with medical records. Never-
the-less this study sheds light on the important issue of  
determinants of  poor awareness and poor uptake of  PSA 
screening test. It provides an evidence-based guide to na-
tional or regional policymakers and interventionists that 
policies that focus on improving education, incomes and 
health insurance coverage levels could lead to increases in 
awareness and uptake of  PSA screening tests. Decentral-
ization of  PSA screening health information to involve 
the mass media in more significant roles may also im-
prove awareness and uptake levels.
Conclusion
Nigerian men with incomes higher than the World Bank 
defined absolute poverty line and those with health in-
surance cover have greater awareness of  PSA screening 
tests than men below the poverty line or without health 
insurance. Only the poverty status of  these ‘at risk’ men 
determines if  they will proceed to take the PSA screening 
test with men above the poverty line more likely to have 
PSA screening tests. This study provides evidence-based 
guide that policies focused on improving health insurance 
coverage and incomes could improve awareness and up-
take of  PSA screening test.
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